Login / Signup

Janus kinase 2 (JAK2) inhibitors in the treatment of multiple myeloma: modulating the myeloma immune microenvironment.

Hannah V GilesGuy Pratt
Published in: British journal of haematology (2020)
Keyphrases
  • multiple myeloma
  • stem cells
  • signaling pathway
  • protein kinase
  • replacement therapy